The MIDAS2 study is looking for people who have severe persisting fatigue after Stroke. The study will test whether the wakefulness medication called ‘Modafinil’ taken for 56 days is safe and can alleviate Stroke-related fatigue in a much larger group of Stroke survivors.
There are currently 18 hospitals across Australia participating in the study.
Participants will receive either 200 mg of modafinil or placebo (an identical tablet with no active ingredients). There is a 50% chance of being in either of these groups.
You may be eligible to participate in this research study if: